Clin Cancer Res 13: 5348–5354 Serum levels of polyclonal IgG, IgA and IgM are usually decreased in patients with multiple myeloma (MM); however, little is known about the prognostic significance ...

Forty-eight patients with multiple myeloma, most of them ambulatory outpatients, at 5 co-operating hospitals,‡ were treated. Patients were entered in the double-blind study by randomized card ...

Multiple myeloma: IgG (50 %), IgA (20 %), IgD (few), free light chains (17 %) Serum light chain quantitation Venous blood sample. Provides a rapid, accurate, quantitative measurement of λ and κ ...

A novel combination for relapsed/refractory multiple myeloma produced responses in about 80% of a heavily treated population, ...

For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage ...

Also, 44.6% of samples with IgG and IgA M-proteins had a normal κ/λ ratio. Of 357 sera that showed no M-protein by IFE, 95.8% exhibited a normal κ/λ ratio. Out of 11 patients with light chain ...